Mindset Wealth Management LLC grew its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 0.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,170 shares of the financial services provider’s stock after purchasing an additional 52 shares during the quarter. CME Group makes up about 2.8% of Mindset Wealth Management LLC’s portfolio, making the stock its 3rd biggest holding. Mindset Wealth Management LLC’s holdings in CME Group were worth $7,703,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. SJS Investment Consulting Inc. increased its holdings in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares in the last quarter. Truvestments Capital LLC purchased a new stake in CME Group in the 3rd quarter worth $26,000. Dunhill Financial LLC increased its holdings in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares in the last quarter. Financial Life Planners purchased a new stake in CME Group in the 4th quarter worth $32,000. Finally, Knuff & Co LLC purchased a new stake in CME Group in the 4th quarter worth $33,000. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Trading Up 0.4 %
NASDAQ CME opened at $266.54 on Friday. The firm’s 50-day moving average is $245.81 and its two-hundred day moving average is $233.74. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $267.91. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a market capitalization of $96.05 billion, a P/E ratio of 27.56, a PEG ratio of 6.76 and a beta of 0.53.
CME Group announced that its board has authorized a share buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.
CME Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. The ex-dividend date is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a yield of 1.88%. CME Group’s dividend payout ratio is 51.71%.
Insiders Place Their Bets
In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the business’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This represents a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the sale, the director now owns 21,873 shares in the company, valued at $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock worth $6,871,496 over the last three months. Company insiders own 0.30% of the company’s stock.
Analysts Set New Price Targets
CME has been the subject of several recent analyst reports. Barclays boosted their price target on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Piper Sandler lifted their target price on shares of CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Oppenheimer lifted their target price on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Royal Bank of Canada lifted their target price on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 13th. Finally, Morgan Stanley boosted their price target on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $238.93.
Get Our Latest Analysis on CME Group
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Which Wall Street Analysts are the Most Accurate?
- 4 Undervalued Growth Stocks to Buy and Hold for the Long Term
- What is the Hang Seng index?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- What is a Bond Market Holiday? How to Invest and Trade
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.